Zist Darou Danesh Company
Zist Darou Danesh Company
Zist Darou Danesh Company is a private specialty pharmaceutical and biopharmaceutical company with a Tehran head office and manufacturing links to Alborz Province. In the Hormuz Group company graph, it matters because it connects recombinant medicines, specialty oncology and neurology products, orphan-drug access, advanced formulation capability, export certification, and Iran's movement toward higher-value pharmaceutical technology. Its profile is central to mapping Iran's domestic substitutes for expensive imported specialty drugs.
Products & Services
Zist Darou Danesh Company researches, develops, manufactures, and markets specialty medicines for complex diseases, including recombinant and chemical pharmaceutical products in oncology, neurology, orphan diseases, dermatology-rheumatology, iron deficiency, endocrinology, diabetes, MS, ALS, cancer, aesthetic drugs, and other specialized therapeutic areas. Its activity includes pharmaceutical R&D, patient support, clinical education, export registration, and GMP-based specialty-drug production.
Investment Relevance
Zist Darou Danesh is relevant for investors assessing Iran's specialty-drug market, biologics and recombinant medicine capability, oncology and neurology demand, orphan-drug access, export potential, and high-value pharmaceutical localization. It can support analysis of how domestic companies move into advanced therapies under sanctions, pricing regulation, and technology constraints. Due diligence should verify ownership, relationship with PMA or related holdings, GMP and EAEU GMP certification status, product registrations, export destinations, clinical evidence, pharmacovigilance systems, API and biologic input sourcing, manufacturing site status, and exposure to intellectual-property or regulatory risk.
Connected Intelligence
This profile is connected to Hormuz taxonomy layers across geography, industry, market exposure, and investment constraints.
Source & Verification Note
Based on public company, official-company, specialty-pharmaceutical, biopharmaceutical, recombinant-drug, GMP, export, product, and market-related information. Further verification is required before treating this profile as verified investment intelligence.